Document is current
Any future updates will be listed below
-
Authors
Hasegawa, Tomoko
Ikeda, Hanako Ohashi
Abe, Hiroyasu
Amino, Yoko
Nakagawa, Takayuki
Tada, Harue
Miyata, Manabu
Oishi, Akio
Morita, Satoshi
Tsujikawa, Akitaka
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI 20J40157)
Japan Intractable Diseases Research Foundation (2019B01)
Mishima Saiichi Memorial Foundation (grant)
Uehara Memorial Foundation (grant)
Takeda Science Foundation (grant)
Bayer Academic Support (grant)
Japan Agency for Medical Research and Development (20ek0109333h0003)
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 13 June 2025
First Online: 1 July 2025
Declarations
:
: T.H. and H.I. were inventors of the studied drug patent (6764233 in Japan). The other authors have no competing interests to declare.
